Global team uncovers genomic secrets behind varied incidence in kidney cancer rates
In a landmark paper published today (1 May, 2024) by the Mutographs team in Nature, they identify new mutational signatures at play in the development of clear cell renal cell carcinoma, of unknown origin, which contribute towards…
Patient advocate Candace Henley and physician-scientist Kimmie Ng are members of the Cancer Grand Challenges OPTIMISTICC team. Together they have helped to set up the programme's flagship study, MICROCOSM.
An…
Amy Schade joined Karen Cichowski’s lab (Brigham and Women's Hospital, Harvard Medical School) as a postdoctoral research fellow in 2019. Karen is Amy’s mentor, and both are part of the Cancer Grand Challenges…
Flaminia Grimaldi, Sara Vogl and Laura Kütt are members of the IMAXT team, working on Theia, an immersive interface to interact with 3D tumours in VR. Their broad range of expertise – a VR artist, a designer and an…
Michele Cleary is CEO of The Mark Foundation for Cancer Research, co-funders of the Cancer Grand Challenges SPECIFICANCER team. For International Women’s Day 2021 and our Cancer Grand Challenges Women's Week series, we…
Barbara Rimer is our newest member of the Cancer Grand Challenges Scientific Committee. For International Women’s Day 2021 and as part of our Cancer Grand Challenges Women's Week series, we caught up to discuss the…
Their donation, which rises to £1.25m with Gift Aid, will help scientists uncover secrets of the microbiome, which could lead to new colorectal cancer treatments.
“I sold my company back in July, and we’re lucky to…
In October, we posed 9 new challenges to the research community, each with the potential to change the way we think about cancer. Through our new blog series, members of our Cancer Grand Challenges Scientific Committee…
In October, we posed 9 new challenges to the research community, each with the potential to change the way we think about cancer. Through our new blog series, members of our Cancer Grand Challenges Scientific Committee …
In a new Science paper, members of the Cancer Grand Challenges IMAXT team announce ExSeq – new technology that can create nanoscale-resolution genomic maps of tumour samples by combining the expansion of biological…